BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Dr Reddys Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500124
ISIN Demat
INE089A01031
Book Value (Rs)
345.7486895
NSE Symbol
DRREDDY
Divident Yield %
0.62
Market Cap
(Rs In Cr.)
107,164
P/E (TTM)
15.55
EPS (TTM)
82.59
Face Value
(Rs)
1
Back
Dr Reddy's Laboratories consolidated net profit rises 7.28% in the September 2025 quarter
25-Oct-25   Hrs IST

Net profit of Dr Reddy's Laboratories rose 7.28% to Rs 1347.10 crore in the quarter ended September 2025 as against Rs 1255.70 crore during the previous quarter ended September 2024. Sales rose 9.84% to Rs 8804.90 crore in the quarter ended September 2025 as against Rs 8016.10 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales8804.908016.10 10
OPM %22.8325.90 -
PBDT2249.402314.40 -3
PBT1744.801917.40 -9
NP1347.101255.70 7

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)